RETRANSPLANTATION OF PATIENTS WITH SEVERE POSTTRANSPLANT HEPATITIS B IN THE FIRST ALLOGRAFT

Abstract

We conclude that patients with recurrent or de novo hepatitis B after OLTX can be successfully retransplanted using aggressive immunoprophylaxis to prevent HBV reinfection. The failure of HBIg therapy in one patient underscores the need for other effective adjunctive anti-HBV modalities.